European stock and US equity futures climb vaccine expectation and M&A action

Capped vials of the COVID-19 vaccine candidate from the University of Oxford, which resumed testing after a pause last week.

Vincenzo Pinto / Agence France-Presse / Getty Images

European shares rose on Monday, with US equity futures driven by news of the vaccine’s expectation, mergers and acquisitions.

Stoxx Europe 600 Index SXXP,
Increased 0.3% after ending the previous week almost 1.7% higher, 7. The best weekly return since the week ending August. German Dax Dax,
0.3% achieved, French CAC 40 PX1,
+ 0.15%
Rose 0.4%, while the FTSE 100 Index UKX,
The flat was trading.

Investors will hear from the Federal Reserve, the Bank of England and the Bank of Japan in the coming days on a busy week for central bank meetings.

Wall Street was also pointing to a strong start with the Nasdaq-100 futures NQ00,
+ 1.12%
145 points or 1.3% increase, while the S&P 500 futures ES00,
+ 0.96%
38.95 points or 1.2%, and the Dow Jones Industrial Average futures made YM00 cry
+ 0.77%
Jumped 278 points, or 1%.

Those gains came at a week’s height for Wall Street with the Dow DJIA,
+ 0.47%
Dropping 1.7%, S&P 500 SPX,
2.5% decline and Nasdaq comp,
Its 4.1% drop, its worst weekly loss since the week ending March 20.

Renewed hopes on the coronovirus vaccine also helped improve at the beginning of the week.

PFE of Pfizer Inc.
+ 1.17%
Chief Executive Officer Albert Borla said in an interview on Sunday that the drugmaker should know if its COVID-19 vaccine candidate will work until the end of October – and if approved, distribute it to the US by the end of the year can go. Pfizer is partnering with German drugmaker BioNotech BNTT.
+ 6.42%
On the development of the vaccine.

Oxford University also announced on Saturday that it would begin a trial for the coronovirus candidate, which is developing alongside AstraZeneca Ezanne,
The study was stopped after a UK patient fell ill last week. Oxford University said it was considered safe to continue. AstraZeneca shares rose 0.5%.

US-based Gilead Sciences Inc. GILD on Sunday announced a $ 21 billion deal to buy biotech Immunomedics Inc. IMMU, a leading breast cancer drug maker.

Japanese technology conglomerate Softbank Group Corp announced a $ 40 billion deal late Sunday to sell UK-based microprocessor designer Arm Holdings to chipmaker Nvidia NVDA.
For a mixture of cash and stock.

The technology sector was also lifted by M&A with shares of the German software group SAP SE SAP,
+ 0.01%
0.3% and chip equipment manufacturer ASML Holding NV ASML,
+ 0.62%

+ 0.35%
Up to 0.3%.

And the race for TikTok is heating up. Software Group Oracle Corp ORCL,
The video-sharing app was tipped to take over the US after China’s Bytdans explicitly rejected an offer from technology giant Microsoft Corp MSFT.
But in the latest twist, Chinese state media say ByteDance has also turned down Oracle.

Elsewhere, Euronext NV ENX,
Monday said it has submitted a non-binding offer to acquire Borsa Italia from London Stock Exchange Group plc LSE.
Pan-European Exchange partnered with Italian lenders Kaspa Depositi e Presti Equity and Intesa Sanpolo Spa ISP,
On offer. Euronext shares fell 0.2% and London Stock Exchange shares fell 0.5%.


Leave a Reply

Your email address will not be published.